- Home
- SHFS vs GLMD Comparison
SHFS vs GLMD Comparison
Compare SHFS & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHFS
- GLMD
- Stock Information
- Founded
- SHFS 2015
- GLMD 2000
- Country
- SHFS United States
- GLMD Israel
- Employees
- SHFS N/A
- GLMD N/A
- Industry
- SHFS Finance: Consumer Services
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- SHFS Finance
- GLMD Health Care
- Exchange
- SHFS Nasdaq
- GLMD Nasdaq
- Market Cap
- SHFS 9.5M
- GLMD 8.0M
- IPO Year
- SHFS N/A
- GLMD 2014
- Fundamental
- Price
- SHFS $2.74
- GLMD $1.35
- Analyst Decision
- SHFS
- GLMD Hold
- Analyst Count
- SHFS 0
- GLMD 1
- Target Price
- SHFS N/A
- GLMD N/A
- AVG Volume (30 Days)
- SHFS 76.8K
- GLMD 75.2K
- Earning Date
- SHFS 11-12-2025
- GLMD 11-13-2025
- Dividend Yield
- SHFS N/A
- GLMD N/A
- EPS Growth
- SHFS N/A
- GLMD N/A
- EPS
- SHFS N/A
- GLMD N/A
- Revenue
- SHFS $11,720,493.00
- GLMD N/A
- Revenue This Year
- SHFS N/A
- GLMD N/A
- Revenue Next Year
- SHFS N/A
- GLMD N/A
- P/E Ratio
- SHFS N/A
- GLMD N/A
- Revenue Growth
- SHFS N/A
- GLMD N/A
- 52 Week Low
- SHFS $1.84
- GLMD $1.15
- 52 Week High
- SHFS $10.53
- GLMD $3.94
- Technical
- Relative Strength Index (RSI)
- SHFS 36.04
- GLMD 42.88
- Support Level
- SHFS $2.77
- GLMD $1.33
- Resistance Level
- SHFS $3.52
- GLMD $1.53
- Average True Range (ATR)
- SHFS 0.40
- GLMD 0.09
- MACD
- SHFS -0.19
- GLMD -0.01
- Stochastic Oscillator
- SHFS 6.38
- GLMD 7.41
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.